Study Identifies New Mechanism of Antifungal Resistance in Cryptococcus neoformans
Researchers have identified a novel epigenetic mechanism — transient heterochromatin islands — that enables Cryptococcus neoformans to develop unstable resistance to the antifungal drug fluconazole, independent of previously known chromosomal changes. C. neoformans kills an estimated 180,000 people annually, predominantly immunocompromised HIV patients in sub-Saharan Africa where fluconazole is often the only affordable treatment. The finding suggests antifungal resistance may be more widespread and harder to detect than current genomic surveillance methods can capture.
A new preprint study on bioRxiv reports that Cryptococcus neoformans, a fungal pathogen responsible for roughly 180,000 deaths per year, can develop resistance to fluconazole through a mechanism involving transient islands of histone H3 lysine 9 methylation-dependent heterochromatin — a form of epigenetic gene silencing — rather than through the chromosomal aneuploidy previously thought to be the primary driver. These heterochromatin islands appear at multiple genomic locations in clinical isolates from African patients and can dissipate when fluconazole is removed, only to re-emerge upon re-exposure, making the resistance inherently unstable and reversible. Deletion experiments confirmed that specific genes located within these islands, when silenced, increase fluconazole resistance in otherwise wild-type cells, pointing to altered gene expression as the functional mechanism. Similar heterochromatin-based resistance has recently been documented in the ascomycete fission yeast Schizosaccharomyces pombe and in Mucor circinelloides complex fungi, raising the possibility that epigenetic resistance mechanisms are broadly distributed across pathogenic fungal species. A critical clinical challenge highlighted by the authors is that this form of resistance is invisible to standard DNA sequencing-based surveillance, since it involves epigenetic rather than genetic changes, complicating efforts to monitor and manage antifungal resistance in resource-limited settings.
What's missing
The authors do not address whether heterochromatin island-mediated resistance translates to clinical treatment failure in patients, nor do they propose specific alternative detection methods for clinical surveillance. The frequency and clinical prevalence of this mechanism relative to aneuploidy-based heteroresistance in patient populations remains unquantified.
What different sources said
- bioRxivCenter
Variable ectopic heterochromatin islands provide an alternative route to antifungal heteroresistance in Cryptococcus neoformans
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.